Therapeutic drug monitoring of voriconazole: a case report of multiple drug interactions in a patient with an increased CYP2C19 activity

BACKGROUND: Voriconazole is metabolized by cytochrome P450 (CYP) 2C19 and CYP 3A4. Drug-drug interactions and genetic polymorphisms modulate their activities. CASE PRESENTATION: A 35-year old African female patient with resistant HIV and a cerebral mass of unknown origin was treated with voriconazol...

Descripción completa

Detalles Bibliográficos
Autores principales: Bouatou, Yassine, Samer, Caroline Flora, Ing Lorenzini, Kuntheavy Roseline, Daali, Youssef, Daou, Samira, Fathi, Marc, Rebsamen, Michela, Desmeules, Jules, Calmy, Alexandra, Escher, Monica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4130425/
https://www.ncbi.nlm.nih.gov/pubmed/25120580
http://dx.doi.org/10.1186/1742-6405-11-25

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4130425/
https://www.ncbi.nlm.nih.gov/pubmed/25120580
http://dx.doi.org/10.1186/1742-6405-11-25

Ejemplares similares